Articles Tagged With: Contraception
-
Multipurpose methods show research advances
Strides are being made in development of multipurpose prevention technologies, defined as a single product or strategy configured for at least two sexual and reproductive health prevention indications: unintended pregnancy, HIV, and other sexually transmitted infections. -
How to address deaths from ovarian cancer
A woman in her late 40s dies less than a year after ovarian cancer is diagnosed. She has three daughters ranging from 15 to 25 years of age. How can ovarian cancer be prevented in these three young women? How can ovarian cancer be prevented during the lifetime of ANY woman, whether or not she has a family history of ovarian cancer?
-
Get practice up to speed on LARC methods
Clinics looking to increase use of long-acting reversible contraceptive (LARC) methods have tools and evidence to support their actions. -
Pills are still popular with many women
According to results from the 2013 Contraceptive Technology Update Contraception Survey, while many women continue to pick combined oral contraceptives (OCs), other options are making inroads on the popular choice. -
Add screening for violence by intimate partners
Intimate partner violence (IPV) and reproductive and sexual coercion disproportionately affect women. Such behavior is aimed at establishing control of one partner over the other. -
Contraceptive implant makes inroads as birth control option
Women continue to choose long-acting reversible contraceptive (LARC) methods, say respondents to the 2013 Contraceptive Technology Update Contraception Survey. -
Extended OC use, Quick Start has arrived
Responses to the 2013 Contraceptive Technology Update Contraception Survey indicate that many clinicians have moved to remove one hurdle to contraception by adopting the Quick Start method of method initiation. -
Contraception focus: Combined hormones
Results of the 2013 Contraceptive Technology Update Contraception Survey indicate that use of the NuvaRing contraceptive vaginal ring and the Evra contraceptive patch is consistent with 2012's figures. -
Check Nortrel stock — Barr Labs issues recall
If you have any patients who use 28-day packages of Nortrel 7/7/7 oral contraceptives (OCs), be sure your clinic has initiated its patient notification plan following the July 9, 2003, voluntary recall issued by the pills manufacturer, Barr Laboratories of Pomona, NY. -
More women know about emergency contraception, but can they get it?
The word is getting out about emergency contraception (EC). A just-released national survey reports that two-thirds of women ages 18-44 are aware that there is something a woman can do to prevent pregnancy in the few days following sexual intercourse.